Scientific article
Meta-analysis
OA Policy
English

Systemic corticosteroids for the management of cancer - related breathlessness (dyspnoea) in adults (Review)

Published in

Cochrane Database of Systematic Reviews, no. 2, CD012704

Publication date

2019

Abstract

Dyspnoea is a common symptom in advanced cancer, with a prevalence of up to 70% among patients at end of life. The cause of dyspnoea is often multifactorial, and may cause considerable psychological distress and suffering. Dyspnoea is often undertreated and good symptom control is less frequently achieved in people with dyspnoea than in people with other symptoms of advanced cancer, such as pain and nausea. The exact mechanism of action of corticosteroids in managing dyspnoea is unclear, yet corticosteroids are commonly used in palliative care for a variety of non-specific indications, including pain, nausea, anorexia, fatigue and low mood, despite being associated with a wide range of adverse effects. In view of their widespread use, it is important to seek evidence of the effects of corticosteroids for the management of cancer-related dyspnoea.

UNIGE research groups

Citation (ISO format)

HAYWOOD, Alison et al. Systemic corticosteroids for the management of cancer - related breathlessness (dyspnoea) in adults (Review). In: Cochrane Database of Systematic Reviews, 2019, n° 2, p. CD012704. doi: 10.1002/14651858.CD012704.pub2

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1469-493X
275views
564downloads

Technical informations

Creation

18/11/2019 13:23:00

First validation

18/11/2019 13:23:00

Update

15/03/2023 21:57:31

Status update

15/03/2023 21:57:30

Last indexation

31/10/2024 18:41:40
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated